We are vaccinating patients ages 12+. Learn more:
Vaccines | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker | Email Alerts
Enter the last name, specialty or keyword for your search below.
The Veltri-Partin Fisher Biomarker Laboratory strives to improve the early detection, staging, monitoring and prognosis of prostate cancer and other urologic cancers with the use of biomarkers.
The Shawn Lupold Laboratory studies the biology of urologic malignancies, like prostate cancer, to create new experimental diagnostic, prognostic and therapeutic agents.
Language Assistance Available:
© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
